scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/0022-2836(91)90617-F |
P698 | PubMed publication ID | 1988675 |
P2093 | author name string | Olson AJ | |
Mian IS | |||
Bradwell AR | |||
P2860 | cites work | The Protein Data Bank: a computer-based archival file for macromolecular structures | Q27860989 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 133-151 | |
P577 | publication date | 1991-01-01 | |
P1433 | published in | Journal of Molecular Biology | Q925779 |
P1476 | title | Structure, function and properties of antibody binding sites | |
P478 | volume | 217 |
Q36656040 | 2-(2-Hydroxy-5-nitrobenzylidene)-1,3-indanedione versus Fluorescein Isothiocyanate in Interaction with Anti-hFABP Immunoglobulin G1: Fluorescence Quenching, Secondary Structure Alteration and Binding Sites Localization |
Q27651036 | A Dominant Conformational Role for Amino Acid Diversity in Minimalist Protein–Protein Interfaces |
Q36293727 | A Gradient of Sitewise Diversity Promotes Evolutionary Fitness for Binder Discovery in a Three-Helix Bundle Protein Scaffold. |
Q30820933 | A Rough Energy Landscape to Describe Surface-Linked Antibody and Antigen Bond Formation |
Q27670852 | A combinatorial histidine scanning library approach to engineer highly pH-dependent protein switches |
Q36818734 | A combinatorial library strategy for the rapid humanization of anticarcinoma BR96 Fab. |
Q40155579 | A comparative analysis on the physicochemical properties of tick-borne encephalitis virus envelope protein residues that affect its antigenic properties |
Q38315995 | A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints |
Q51620484 | A novel Arg H52/Tyr H33 conservative motif in antibodies: A correlation between sequence of antibodies and antigen binding. |
Q33573612 | A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy |
Q52384767 | A skewed distribution of amino acids at recognition sites of the hypervariable region of immunoglobulins. |
Q34104980 | A universal combinatorial design of antibody framework to graft distinct CDR sequences: a bioinformatics approach |
Q64101990 | ALTHEA Gold Libraries™: antibody libraries for therapeutic antibody discovery |
Q47567087 | Allosteric control of antibody-prion recognition through oxidation of a disulfide bond between the CH and CL chains |
Q33222594 | Alternative views of functional protein binding epitopes obtained by combinatorial shotgun scanning mutagenesis |
Q30420540 | Amino acid preferences at protein binding sites |
Q48382744 | Amino acid sequences and hapten binding of catalytic and noncatalytic antibodies against N(alpha)-(5'-phosphopyridoxyl)-L-lysine |
Q37728775 | An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability |
Q35865834 | Anti-DNA antibody mediated catalysis is isotype dependent |
Q33746862 | Anti-DNA autoantibodies and systemic lupus erythematosus |
Q41439989 | Anti-DNA autoantibodies: the other DNA-binding proteins. |
Q27742018 | Antibody fragment Fv4155 bound to two closely related steroid hormones: the structural basis of fine specificity |
Q40125548 | Antibody humanization by molecular dynamics simulations-in-silico guided selection of critical backmutations |
Q36853419 | Antibody humanization using monovalent phage display |
Q43820158 | Antibody i-Patch prediction of the antibody binding site improves rigid local antibody-antigen docking |
Q36238794 | Antigen-antibody interface properties: composition, residue interactions, and features of 53 non-redundant structures |
Q34191098 | Antigen-binding site anatomy and somatic mutations in antibodies that recognize different types of antigens. |
Q60947009 | Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis |
Q71601708 | Antiidiotypic antibodies: methods, applications, and critique |
Q33887941 | Atomic structure of an alphabeta T cell receptor (TCR) heterodimer in complex with an anti-TCR fab fragment derived from a mitogenic antibody |
Q41316577 | Both VH and VL chains of polyreactive IgM antibody are required for polyreactivity: expression of Fab inEscherichia coli |
Q72768367 | CIDNP study of the aromatic side chain interactions in myotoxin alpha |
Q38339374 | Characterization and application of a DNA aptamer binding to L-tryptophan. |
Q74268401 | Circulating human B cells that express surrogate light chains and edited receptors |
Q71699017 | Comparative docking studies on ligand binding to the multispecific antibodies IgE-La2 and IgE-Lb4 |
Q42846994 | Comparison of protein-protein interactions in serine protease-inhibitor and antibody-antigen complexes: implications for the protein docking problem |
Q42643055 | Comparison of rheumatoid factors of rheumatoid arthritis patients, of individuals with mycobacterial infections and of normal controls: evidence for maturation in the absence of an autoimmune response |
Q71868769 | Comparison of the immunoglobulin heavy-chain complementarity determining region-3 structure among the DNA sequences and the mu- and gamma-transcripts in human B-lineage cells |
Q36212921 | Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle |
Q43825546 | Computational 3-D modeling and site-directed mutation of an antibody that binds Neu2en5Ac, a transition state analogue of a sialic acid |
Q72109481 | Computer-aided molecular modeling of the binding site architecture for eight monoclonal antibodies that bind a high potency guanidinium sweetener |
Q40119666 | Conformation-controlled binding kinetics of antibodies |
Q73497425 | Conformational isomerism of IgG antibodies |
Q37209384 | Conservation and diversity in the ultralong third heavy-chain complementarity-determining region of bovine antibodies |
Q35794080 | Construction of a Semisynthetic Human VH Single-Domain Antibody Library and Selection of Domain Antibodies against α-Crystalline of Mycobacterium tuberculosis |
Q27658806 | Contribution of Asparagine Residues to the Stabilization of a Proteinaceous Antigen-Antibody Complex, HyHEL-10-Hen Egg White Lysozyme |
Q27650026 | Critical contribution of aromatic rings to specific recognition of polyether rings. The case of ciguatoxin CTX3C-ABC and its specific antibody 1C49 |
Q31172558 | Cross-reactivity and conformational multiplicity of an anti-polycyclic aromatic hydrocarbon mAb |
Q27681282 | Crystal Structure of Interleukin-6 in Complex with a Modified Nucleic Acid Ligand |
Q27731338 | Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2 |
Q27633163 | Crystal structure of a recombinant anti-estradiol Fab fragment in complex with 17beta -estradiol |
Q27729913 | Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin |
Q27621426 | Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts |
Q91788842 | Crystal structure, epitope, and functional impact of an antibody against a superactive FVIIa provide insights into allosteric mechanism |
Q27734752 | Crystal structures of CheY mutants Y106W and T87I/Y106W. CheY activation correlates with movement of residue 106 |
Q41912569 | Crystal structures of human Fabs targeting the Bexsero meningococcal vaccine antigen NHBA |
Q52312646 | Crystal structures of thrombin in complex with chemically modified thrombin DNA aptamers reveal the origins of enhanced affinity. |
Q27748756 | Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity |
Q52430167 | Development of an extended simulated annealing method: Application to the modeling of complementary determining regions of immunoglobulins |
Q34179284 | Differences in electrostatic properties at antibody-antigen binding sites: implications for specificity and cross-reactivity |
Q46212545 | Disordered C-terminal domain of tyrosyl-tRNA synthetase: secondary structure prediction |
Q48051459 | Distance-Guided Forward and Backward Chain-Growth Monte Carlo Method for Conformational Sampling and Structural Prediction of Antibody CDR-H3 Loops |
Q71871358 | Distributions of the use frequencies of amino acids in the hypervariable regions of immunoglobulins |
Q92296514 | Diverse Antibody Responses to Conserved Structural Motifs in Plasmodium falciparum Circumsporozoite Protein |
Q41753346 | Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities |
Q31152113 | DrugScorePPI knowledge-based potentials used as scoring and objective function in protein-protein docking |
Q27654007 | Efalizumab binding to the LFA-1 L I domain blocks ICAM-1 binding via steric hindrance |
Q90740652 | Effect of Peroxide- Versus Alkoxyl-Induced Chemical Oxidation on the Structure, Stability, Aggregation, and Function of a Therapeutic Monoclonal Antibody |
Q64255753 | Effective binding to protein antigens by antibodies from antibody libraries designed with enhanced protein recognition propensities |
Q41961609 | Effects of mutation at the D-JH junction on affinity, specificity, and idiotypy of anti-progesterone antibody DB3. |
Q38272342 | Electrostatic contributions to protein-protein interactions: fast energetic filters for docking and their physical basis |
Q26766060 | Embracing proteins: structural themes in aptamer-protein complexes |
Q36281533 | Energetic analysis of an antigen/antibody interface: alanine scanning mutagenesis and double mutant cycles on the HyHEL-10/lysozyme interaction |
Q28246653 | Engineering of recombinant crystallization chaperones |
Q36714582 | Evolution of specific antigen recognition: size reduction and restricted length distribution of the CDRH3 regions in the rainbow trout |
Q34675779 | Exploiting cross-reactivity to neutralize two different scorpion venoms with one single chain antibody fragment |
Q34478580 | First molecular and biochemical analysis of in vivo affinity maturation in an ectothermic vertebrate. |
Q47721816 | Fluorescence spectroscopy of monoclonal antibodies produced against the fluorescyl hapten conjugated through the xanthene ring |
Q36122012 | Generation and analyses of human synthetic antibody libraries and their application for protein microarrays |
Q47916320 | Generation and selection of naïve Fab library for parasitic antigen: Anti-BmSXP antibodies for lymphatic filariasis. |
Q34018972 | High resolution structures of the 4–4-20 Fab-fluorescein complex in two solvent systems: effects of solvent on structure and antigen-binding affinity |
Q28257550 | High-affinity binders selected from designed ankyrin repeat protein libraries |
Q27644389 | High-affinity single-domain binding proteins with a binary-code interface |
Q27650565 | How protein recognizes ladder-like polycyclic ethers. Interactions between ciguatoxin (CTX3C) fragments and its specific antibody 10C9 |
Q34426559 | Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity |
Q24561842 | Humanization of an anti-p185HER2 antibody for human cancer therapy |
Q27643972 | Hydrophobic Surface Burial Is the Major Stability Determinant of a Flat, Single-layer β-Sheet |
Q24679395 | Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design |
Q38999059 | Identification and fine mapping of a linear B cell epitope of human vimentin |
Q33870575 | Identification of nitrated immunoglobulin variable regions in the HIV-infected human brain: implications in HIV infection and immune response. |
Q51930932 | Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties. |
Q28751452 | Immunoglobulin heavy chain diversity in Pteropid bats: evidence for a diverse and highly specific antigen binding repertoire |
Q34261353 | Immunoglobulin variable region structure and B-cell malignancies |
Q90481861 | Immunoproteomic Identification of Noncarbohydrate Antigens Eliciting Graft-Specific Adaptive Immune Responses in Patients with Bovine Pericardial Bioprosthetic Heart Valves |
Q29048182 | Improving the accuracy of the structure prediction of the third hypervariable loop of the heavy chains of antibodies |
Q90212285 | In Silico Methods in Antibody Design |
Q90320727 | In vitro and in silico assessment of the developability of a designed monoclonal antibody library |
Q37212410 | In vitro selection of an RNA epitope immunologically cross-reactive with a peptide |
Q38550551 | Inorganic nanoparticles engineered to attack bacteria |
Q43975038 | Interactions between anti-ErbB2 antibody A21 and the ErbB2 extracellular domain provide a basis for improving A21 affinity |
Q33594252 | Interactions of protein antigens with antibodies |
Q37773248 | Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science |
Q41374759 | Label-free Fab and Fc affinity/avidity profiling of the antibody complex half-life for polyclonal and monoclonal efficacy screening. |
Q36003473 | Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity |
Q42029789 | Large-scale analysis of human heavy chain V(D)J recombination patterns |
Q44628372 | Large-scale analysis of somatic hypermutations in antibodies reveals which structural regions, positions and amino acids are modified to improve affinity |
Q27679807 | Malachite Green Mediates Homodimerization of Antibody VL Domains to Form a Fluorescent Ternary Complex with Singular Symmetric Interfaces |
Q24672879 | Mapping the binding domain of immunoglobulin light chains for Tamm-Horsfall protein |
Q47565290 | Mechanisms of recognition of amyloid-β (Aβ) monomer, oligomer, and fibril by homologous antibodies |
Q34183601 | Modeling the Binding Sites of Anti-Hen Egg White Lysozyme Antibodies HyHEL-8 and HyHEL-26: An Insight into the Molecular Basis of Antibody Cross-Reactivity and Specificity |
Q36277890 | Modulation of antibody affinity by a non-contact residue |
Q48062586 | Molecular characterization of VDJ transcripts from a newborn piglet |
Q27680420 | Molecular characterization of monoclonal antibodies that inhibit acetylcholinesterase by targeting the peripheral site and backdoor region |
Q27676503 | Molecular determinants for antibody binding on group 1 house dust mite allergens |
Q27643327 | Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin |
Q40813242 | Molecular structure of eight human autoreactive monoclonal antibodies |
Q27637297 | NMR structural analysis of alpha-bungarotoxin and its complex with the principal alpha-neurotoxin-binding sequence on the alpha 7 subunit of a neuronal nicotinic acetylcholine receptor |
Q36401413 | Natural and man-made V-gene repertoires for antibody discovery. |
Q64241291 | Novel Immune Microlens Imaging for Detection of Antigen and Antibody |
Q35309726 | Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents |
Q33854235 | Origins of specificity and affinity in antibody-protein interactions |
Q31043905 | Partner-aware prediction of interacting residues in protein-protein complexes from sequence data |
Q34483031 | Peptide interactions with G-protein coupled receptors |
Q35854911 | Pore-exposed tyrosine residues of P-glycoprotein are important hydrogen-bonding partners for drugs. |
Q60075871 | Postmodern complexes |
Q52305335 | Prediction of IgE(Lb4)-ligand complex structures by automated docking. |
Q38957602 | Promiscuous antibodies characterised by their physico-chemical properties: From sequence to structure and back |
Q34586128 | Protein engineering with biosynthesized libraries from Bordetella bronchiseptica bacteriophage |
Q34962608 | Pyridoxal-5'-phosphate-dependent catalytic antibodies. |
Q33198154 | Quaternary and subunit structure of Calliphora arylphorin as deduced from electron microscopy, electrophoresis, and sequence similarities with arthropod hemocyanin |
Q41112963 | RNA surfaces as functional mimetics of proteins |
Q32064083 | Recognition of superpotent sweetener ligands by a library of monoclonal antibodies |
Q71477921 | Redefining the minimal antigen-binding fragment |
Q47984628 | Relation between the heavy chain complementarity region 3 characteristics and rheumatoid factor binding properties |
Q71942207 | Role of Tyr Residues in the Contact Region of Anti-lysozyme Monoclonal Antibody HyHEL10 for Antigen Binding |
Q46217877 | Secondary structure prediction and unrefined tertiary structure prediction for cyclin A, B, and D. |
Q28817946 | Simple, Scalable Proteomic Imaging for High-Dimensional Profiling of Intact Systems |
Q38342345 | Site-specific mutagenesis of a recombinant anti-single-stranded DNA Fab. Role of heavy chain complementarity-determining region 3 residues in antigen interaction |
Q42417730 | Stacking and energetic contribution of aromatic islands at the binding interface of antibody proteins |
Q90987050 | Strong Enrichment of Aromatic and Sulfur-Containing Residues in Ligand-Protein Binding Sites |
Q58764092 | Structural Basis of Pan-Ebolavirus Neutralization by an Antibody Targeting the Glycoprotein Fusion Loop |
Q71937510 | Structural classification of CDR-H3 in antibodies |
Q27647150 | Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon' |
Q41945566 | Structural features of interfacial tyrosine residue in ROBO1 fibronectin domain-antibody complex: Crystallographic, thermodynamic, and molecular dynamic analyses. |
Q34322939 | Structural insights for engineering binding proteins based on non-antibody scaffolds |
Q52297894 | Structural model of the anti-snake-toxin antibody, M alpha 2,3. |
Q38550766 | Structural models of antibody variable fragments: a method for investigating binding mechanisms |
Q30400464 | Structural reconstruction of protein ancestry |
Q33867521 | Structural requirements of the major protective antibody to Haemophilus influenzae type b |
Q27765157 | Structure of an Fab fragment against a C-terminal peptide of hCG at 2.0 A resolution |
Q27742037 | Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes |
Q34045535 | Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120. |
Q35834694 | Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies |
Q33265617 | Synthetic antibodies as therapeutics |
Q33205837 | Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition |
Q34394742 | Tailored amino acid diversity for the evolution of antibody affinity |
Q91473458 | Targeting mutant p53-expressing tumours with a T cell receptor-like antibody specific for a wild-type antigen |
Q37864919 | The biology of immunoglobulin free light chains and kidney injury |
Q27677854 | The crystal structure of an octapeptide repeat of the Prion protein in complex with a Fab fragment of the POM2 antibody |
Q31118966 | The development of a universal in silico predictor of protein-protein interactions |
Q54558927 | The functional architecture of an acetylcholine receptor-mimicking antibody. |
Q33419652 | The importance of being tyrosine: lessons in molecular recognition from minimalist synthetic binding proteins |
Q53700837 | The importance of handling high-value biologicals: Physico-chemical instability and immunogenicity of monoclonal antibodies. |
Q47794721 | The interfacial character of antibody paratopes: analysis of antibody-antigen structures |
Q35864160 | The proteome of postsurgical pancreatic juice |
Q33993576 | The recognition of proteins and peptides by antibodies |
Q40172508 | The unfolding/denaturation of immunogammaglobulin of isotype 2b and its F(ab) and F(c) fragments |
Q30374518 | Thermodynamics of antibody-antigen interaction revealed by mutation analysis of antibody variable regions. |
Q27642097 | Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2 |
Q35609743 | Tyrosine 106 of CheY plays an important role in chemotaxis signal transduction in Escherichia coli |
Q27729774 | Uncoupled phosphorylation and activation in bacterial chemotaxis. The 2.1-A structure of a threonine to isoleucine mutant at position 87 of CheY |
Q38195522 | Understanding and applying tyrosine biochemical diversity |
Q27675037 | Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets |
Q73256218 | Unusual amino acid usage in the variable regions of mercury-binding antibodies |
Search more.